Life Line Screening offers high quality non-invasive and painless screening for several diseases. These screening are designed to provide the most accurate results while limiting the amount of discomfort a client goes through during preparation and the actual lifeline screening. Whenever a process involves blood screening, the procedure used to draw the blood from the client’s finger is simple and causes minimal pain.
At Life Line Screening, there is little to no preparation needed for most screenings. This means that a patient can drop in for some of the testing at almost any time. For some lifeline screening, a patient will be required to prepare slightly longer. To this end, clients are encouraged to follow the guidelines posted on the company’s website. Below are some of the common diseases screened for at Life Line Screening. Tips on how to prepare for their screening are included.
Carotid artery disease, popularly known as stroke, requires a simple preparation. A client going for lifeline screening of the disease is encouraged to wear a short-sleeved shirt or blouse that is open at the collar. Tops such as turtlenecks are discouraged. Another form of stroke, Atrial fibrillation, is also screened at the organization. For this particular disease, there are additional preparations compared to Carotid artery disease. While going for this screening, one should avoid applying lotion/oil, watch, pantyhose and tight clothing.
Patients going for abdominal aortic aneurysm should wear loose fitting two-piece clothes. The client should also fast for at least four hours before the screening. It is further recommended that the last meal should be light; preferably half of one’s normal serving. Patients who are diagnosed with diabetes and other individuals who are on medications should adhere to their medication plan.
Hs-CRP or elevated C-reactive protein screening requires no preparation. It means that client can go for this screening whenever he or she is free. Loose clothing is needed for ankle-brachial index screening. The top of the two-piece clothing should be short sleeved. Another screening done at Life Line Screening is complete lipid panel screening. This lifeline screening is ideal for patients having high cholesterol levels. For accurate results, patients should observe twelve hours of fasting before going for this screening.
Life Line Screening offers clients a discounted package called 6 for Life Package. This package allows clients to be screened for six diseases at an affordable price. When going for the 6 for Life Package, a patient should fast for 12 hours before the screening. He or she should also wear two-piece outfit with short sleeves and open collars. During fasting, one is allowed to drink water and follow his or her medication plan.
Life Line Screening info: www.lifelinescreening.com/What-We-Do/What-We-Screen-For
Mikhail Blagosklonny is a living legend in the oncology world for his outstanding research contributions. Professor Blagosklonny’s lifetime research has focused on the correlation between the onset of various cancers and age. Mikhail’s objective is to research and figure out the most efficient and affordable treatments for particular cancer strains. The current treatment modalities used to deal with cancer often result in the indiscriminate killing of normal cells. This eminent researcher believes it won’t be long till his research team or others come up with the next-generation of advanced cancer treatments.
Inspiration and Influential Figure
Dr. Mikhail’s significant contributions are an inspiration to countless numbers of young people and he’s equally admired by his academic peers. Today, the existing cancer remedies and solutions are way out of reach to the regular folks, financially. To a significant majority of cancer victims, therapy and cures are a luxury and that is what worries the researcher the most. Dr. Mikhail hopes to live in a future where every cancer patient has easy access to affordable and efficient cancer treatments, at all times.
If there’s one thing that Mikhail Blagosklonny learned by being in the Fastlane of the cancer research realm, it must be the about the power of collaboration. Oncology is a mind-boggling niche with new research findings being released every day. This humungous data makes it nearly impossible for anyone professor or a research team to make breakthroughs in their cancer treatment quests. That’s why Dr. Blagosklonny decided to co-found a unique online peer-to-peer medical research data publishing journal called Oncotarget. Oncotarget went ahead to become one of the biggest research, publishing platforms of our times. Today, Oncotarget contains a wealth of cancer-related research that serves as a vital lifeline for countless graduate students and medical researchers.
In recent times, Dr. Blagosklonny has been experimenting with the potent anti-fungal drug, Rapamycin. Rapamycin, also traded under the generic name, Sirolimus, is used worldwide to reduce organ rejection after transplants. Studies have revealed that Sirolimus also heals lung diseases. The immunosuppressive properties of Sirolimus were first detected by local researchers on the beaches of Easter Island in the 70’s. This drug caught the attention of Dr. Mikhail for the sole reason that it had life-prolonging powers. The researcher envisioned using the anti-aging capabilities of Sirolimus to extend the lives of his cancer patients. It pays that Rapamycin is very easily broken down in the body, hence it doesn’t strain the kidneys during treatments. That is in complete contrast with most of the modern available cancer therapy drugs that end up destroying the kidneys and the liver too.
Research in Progress
Rapamycin is known to discourage the proliferation of cancerous tumors. The drug is highly recommended for patients who’ve just undergone organ transplant operations and have a higher than normal risk of developing tumors. Rapamycin is also used in the both the prevention and treatment of the debilitating congenital disorder, Tuberous Sclerosis Complex (TSC) and Facial angiofibromas. The latter condition manifests as butterfly-shaped rash formations on the face of an affected person. Research is ongoing to determine the exact roles Rapamycin plays in dealing with other severe medical conditions like Alzheimer, Systemic Lupus Erythematosus (SLE) and muscular dystrophy.
For several years, countless companies tried to redefine modern healthcare management. As a result of their failed efforts and a hands-off government, today’s healthcare environment is incredibly complicated. It’s nearly impossible for the average person to navigate their way to the quality medical care everyone deserves.Luckily, InnovaCare Health is the one company making huge strides in their mission of redefining the industry. InnovaCare figured out the best way to make managed care more accessible to everyone is to simply ask people what they need. That’s why InnovaCare places such importance on strong patient-provider relationships.The biggest contributor to InnovaCare’s efforts is the current President and CEO of InnovaCare, Inc., Dr. Richard Shinto. Dr. Shinto is the most qualified leaders at InnovaCare. With more than 20 years of experience in managed care, Dr. Shinto knows exactly what he’s doing and is results-oriented.
Shortly after joining InnovaCare, Dr. Shinto took charge of the company’s Health Plans in Puerto Rico. He used to lead another company, Aveta Inc. but left after its sale in 2012. His complete focus on InnovaCare’s mission made InnovaCare the number one provider of managed care in Puerto Rico in fewer than five years. That accomplishment earned him the CEO position of that particular subsidiary.Young Richard Shinto attended three separate universities. The State University of New York is where he earned his medical degree. He also holds a BS and an MBA; both from universities in California.
Penelope Kokkinides made a huge difference once she rejoined InnovaCare. A few years ago, she left her COO position at InnovaCare to pursue higher-ranking positions at other companies. In 2015, she rejoined InnovaCare and was named the new Chief Administrative Officer. Since rejoining the company, she’s become an indispensable part of the leadership of Rick Shinto.Kokkinides also has more than 20 years of experience in managed care. She specialized in the managed care industry and working with programs like Medicaid and Medicare. She’s one of the best in the business at reconstructing a company’s infrastructure to improve efficiencies.Kokkinides holds more degrees than Dr. Shinto, but she’s focused more on the relationship aspects of the business. She holds three master’s degrees, one a post-master’s advanced degree, from two universities. She holds two master’s from Columbia University School of Public Health.
Source of the article : https://www.openminds.com/market-intelligence/bulletins/innovacare-health-announces-three-additions-leadership-team/
It’s rare for entrepreneurs to turn their attention to medicine, but Eric Lefkofsky is doing it. He made is fortune by starting companies that merge technology finance, such as Groupon, Mediaocean, and Uptake Technologies. He insists that he dislikes the pressure that comes with starting a new company, but that hasn’t stopped him from excelling at it to learn more: http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/ click here.
Eric also directs his money and skills towards philanthropy in his home, Chicago. Eric Lefkofsky supports the Art Institute of Chicago, the Steppenwolf Theatre Company, and he even works as an adjunct professor at the University of Chicago. He’s dedicated to improving both businesses and the world, and his latest project combines both of those passions.
That project is a company called Tempus, which uses data-driven technology and machine learning to help fight cancer. Eric founded Tempus with support from Keywell in 2015, after his wife was diagnosed with cancer. He believes that Tempus has the potential to revolutionize medicine in the same way that Google revolutionized the Internet, simply by making it possible to use a huge amount data to guide treatments.
Tempus isn’t the only company that is trying to bring about that kind of change, but it does have one significant advantage for treatment of the rest. Most of the companies rely on external funding, but Eric has chosen to fund Tempus from his own fortune to make sure that it gets everything that it needs. That allows it to stay lean and focus all of its efforts into making progress, instead of spending time and money on marketing or trying to find more funds.
There is still a lot of work to be done, but Tempus is already making progress. The company is already working on a clinical library and a system to make it easy for doctors to make sense of the data. It is doing so through a system of partnerships with medical groups that send patients to Tempus to provide data to the library in return for access to that library. It’s a complex mix of medicine and technology, but it has the potential to do a great deal of good for patients.